INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS

We analyzed the results of surgical treatment of 42 patients (42 eyes) with neovascular glaucoma on the background of proliferative diabetic retinopathy. Intravitreal injections of anti-VEGF-drugs allow to remove newly formed vessels in anterior chamber angle, to reduce intraocular pressure, to avoi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	V. P. Fokin, S. V. Balalin, T. G. Yefremova, V. N. Potapova
Formato:	article
Lenguaje:	RU
Publicado:	Scientific Сentre for Family Health and Human Reproduction Problems 2016
Materias:	diabetes neovascular glaucoma intravitreal anti-vegf-therapy trans-scleral cyclophotocoagulation Science Q
Acceso en línea:	https://doaj.org/article/ac47b726307f443985fdfe17ce32a68c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ac47b726307f443985fdfe17ce32a68c
record_format	dspace
spelling	oai:doaj.org-article:ac47b726307f443985fdfe17ce32a68c2021-11-23T06:14:36ZINTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS2541-94202587-959610.12737/23792https://doaj.org/article/ac47b726307f443985fdfe17ce32a68c2016-11-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/333https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596We analyzed the results of surgical treatment of 42 patients (42 eyes) with neovascular glaucoma on the background of proliferative diabetic retinopathy. Intravitreal injections of anti-VEGF-drugs allow to remove newly formed vessels in anterior chamber angle, to reduce intraocular pressure, to avoid complications in patients with neovascular glaucoma and the closed anterior chamber angle of the eye. The second stage of the treatment can be laser surgery. This approach helped to reduce intraocular pressure from 28.9 ± 0.9 to 18.5 ± 0.9 mmHg on the background of medical treatment (t > 2.0; p < 0.05). Visual acuity increased from 0.23 ± 0.07 to 0.44 ± 0.08 (t > 2.0; p < 0.05). In patients with NVG and closed anterior chamber angle of the eye, having aching glaucoma the use of laser surgery as the first stage of treatment allows to reduce intraocular pressure and to eliminate pain, and to apply intravitreal anti-VEGF-therapy as the second stage. The mean value of IOP decreased from 30.9 ± 1.2 to 20.1 ± 1.1 mmHg. During the year period, the second stage (intravitreal introduction of Lucentis) was performed in all patients. As a result, IOP was reduced to 17.5 ± 0.09 mmHg. Visual acuity increased from 0.18 ± 0.1 to 0.25 ± 0.07 (p > 0.05).V. P. FokinS. V. BalalinT. G. YefremovaV. N. PotapovaScientific Сentre for Family Health and Human Reproduction Problemsarticlediabetesneovascular glaucomaintravitreal anti-vegf-therapytrans-scleral cyclophotocoagulationScienceQRUActa Biomedica Scientifica, Vol 1, Iss 6, Pp 122-124 (2016)
institution	DOAJ
collection	DOAJ
language	RU
topic	diabetes neovascular glaucoma intravitreal anti-vegf-therapy trans-scleral cyclophotocoagulation Science Q
spellingShingle	diabetes neovascular glaucoma intravitreal anti-vegf-therapy trans-scleral cyclophotocoagulation Science Q V. P. Fokin S. V. Balalin T. G. Yefremova V. N. Potapova INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS
description	We analyzed the results of surgical treatment of 42 patients (42 eyes) with neovascular glaucoma on the background of proliferative diabetic retinopathy. Intravitreal injections of anti-VEGF-drugs allow to remove newly formed vessels in anterior chamber angle, to reduce intraocular pressure, to avoid complications in patients with neovascular glaucoma and the closed anterior chamber angle of the eye. The second stage of the treatment can be laser surgery. This approach helped to reduce intraocular pressure from 28.9 ± 0.9 to 18.5 ± 0.9 mmHg on the background of medical treatment (t > 2.0; p < 0.05). Visual acuity increased from 0.23 ± 0.07 to 0.44 ± 0.08 (t > 2.0; p < 0.05). In patients with NVG and closed anterior chamber angle of the eye, having aching glaucoma the use of laser surgery as the first stage of treatment allows to reduce intraocular pressure and to eliminate pain, and to apply intravitreal anti-VEGF-therapy as the second stage. The mean value of IOP decreased from 30.9 ± 1.2 to 20.1 ± 1.1 mmHg. During the year period, the second stage (intravitreal introduction of Lucentis) was performed in all patients. As a result, IOP was reduced to 17.5 ± 0.09 mmHg. Visual acuity increased from 0.18 ± 0.1 to 0.25 ± 0.07 (p > 0.05).
format	article
author	V. P. Fokin S. V. Balalin T. G. Yefremova V. N. Potapova
author_facet	V. P. Fokin S. V. Balalin T. G. Yefremova V. N. Potapova
author_sort	V. P. Fokin
title	INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS
title_short	INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS
title_full	INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS
title_fullStr	INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS
title_full_unstemmed	INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS
title_sort	intravitreal introduction of lucentis and trans-scleral cyclophotocoagulation in the treatment of neovascular glaucoma in diabetes mellitus
publisher	Scientific Сentre for Family Health and Human Reproduction Problems
publishDate	2016
url	https://doaj.org/article/ac47b726307f443985fdfe17ce32a68c
work_keys_str_mv	AT vpfokin intravitrealintroductionoflucentisandtransscleralcyclophotocoagulationinthetreatmentofneovascularglaucomaindiabetesmellitus AT svbalalin intravitrealintroductionoflucentisandtransscleralcyclophotocoagulationinthetreatmentofneovascularglaucomaindiabetesmellitus AT tgyefremova intravitrealintroductionoflucentisandtransscleralcyclophotocoagulationinthetreatmentofneovascularglaucomaindiabetesmellitus AT vnpotapova intravitrealintroductionoflucentisandtransscleralcyclophotocoagulationinthetreatmentofneovascularglaucomaindiabetesmellitus
_version_	1718417026932801536

INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS

Ejemplares similares